{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:21:20Z","timestamp":1794604880910,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.semarthrit.2022.152034","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:09:47Z","timestamp":1653685787000},"page":"152034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis"],"prefix":"10.1016","volume":"56","author":[{"given":"Haig","family":"Pakhchanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Raiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengappa","family":"Kavadichanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-0455","authenticated-orcid":false,"given":"Maryam","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Karde\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2022.152034_bib0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000512592","article-title":"Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis","volume":"64","author":"Biswas","year":"2021","journal-title":"Intervirology"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0002","article-title":"Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform","volume":"6","author":"Bhaskaran","year":"2021","journal-title":"Lancet Reg Heal - Eur"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152034_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152034_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jinf.2021.01.022","article-title":"COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients","volume":"82","author":"Belsky","year":"2021","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152034_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjophthalmol-2020-316586","article-title":"COVID-19 and immunosuppression: A review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs","volume":"105","author":"Thng","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152034_bib0006","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in Immunocompromised Hosts: What We Know so Far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0007","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0008","unstructured":"Certain Medical Conditions and Risk for Severe COVID-19 Illness | CDC. Accessed June 25, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152034_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: A US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab015","article-title":"High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset","author":"Chatterjee","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab001","article-title":"High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India","author":"Mehta","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152034_bib0012","first-page":"114","article-title":"Infections Are Leading Cause of In-Hospital Mortality in Indian Patients With Inflammatory Myopathy","volume":"27","author":"Muhammed","year":"2021","journal-title":"J ClinRheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152034_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101484","article-title":"Inflammatory muscle disease \u2013 An update","volume":"34","author":"Baig","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152034_bib0014","first-page":"S81","article-title":"The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus","volume":"15","author":"Pauling","year":"2020","journal-title":"Indian J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152034_bib0015","first-page":"1593","article-title":"The aetiopathogenic significance, clinical relevance and therapeutic implications of vasculopathy in idiopathic inflammatory myopathy","volume":"60","author":"Pauling","year":"2021","journal-title":"Revmatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0016","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00296-019-04442-1","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a systematic review","volume":"40","author":"Poddighe","year":"2020","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152034_bib0017","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3899\/jrheum.191274","article-title":"The storm beneath the storm: MAS-HLH in inflammatory myopathies","volume":"47","author":"Schulert","year":"2020","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152034_bib0018","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00296-020-04590-9","article-title":"Macrophage activation syndrome in adult dermatomyositis: a case-based review","volume":"40","author":"Kishida","year":"2020","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152034_bib0019","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejr.2021.06.001","article-title":"Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic","volume":"43","author":"Gupta","year":"2021","journal-title":"Egypt Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0020","article-title":"Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis","volume":"7","author":"Rathore","year":"2020","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152034_bib0021","first-page":"63","article-title":"COVID-19 and Myositis: What We Know So Far","volume":"23","author":"Saud","year":"2021","journal-title":"CurrRheumatol Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152034_bib0022","first-page":"907","article-title":"COVID-19 and myositis-unique challenges for patients","volume":"60","author":"Gupta","year":"2021","journal-title":"Rheumatol (United Kingdom)"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152034_bib0023","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3899\/jrheum.181248","article-title":"Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study","volume":"46","author":"Leclair","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.20386","article-title":"Outcomes of COVID-19 in patients with skin cancer","author":"Raiker","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152034_bib0025","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1053\/j.gastro.2020.08.028","article-title":"Impact of Obesity on Outcomes of Patients With Coronavirus Disease 2019 in the United States: A Multicenter Electronic Health Records Network Study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0026","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.13820820","article-title":"Outcomes of COVID-19 in CKD Patients: A Multicenter Electronic Medical Record Cohort Study","volume":"16","author":"Pakhchanian","year":"2021","journal-title":"Clin J Am SocNephrol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0027","article-title":"Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States","volume":"51","author":"Raiker","year":"2021"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102502","article-title":"SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients","volume":"112","author":"Zen","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0029","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0030","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3389\/fimmu.2020.589474","article-title":"COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics","volume":"11","author":"Spihlman","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152034_bib0031","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152034_bib0032","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.41619","article-title":"COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study","volume":"73","author":"D'Silva","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0033","first-page":"29","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152034_bib0034","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/acr.22039","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0035","first-page":"165","article-title":"Outcomes of Pregnancy in Women With Inflammatory Myositis: A Cohort Study From India","volume":"26","author":"Gupta","year":"2020","journal-title":"J ClinRheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152034_bib0036","first-page":"1021","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"RheumatolInt 2021 416"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0037","first-page":"1","article-title":"Self-identified Race and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients","author":"Charoenngam","year":"2021","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.semarthrit.2022.152034_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejca.2020.08.011","article-title":"Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies","volume":"139","author":"Saini","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0039","first-page":"826","article-title":"The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study","volume":"26","author":"Erdal","year":"2021","journal-title":"Int J ClinOncol 2021 265"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152034_bib0040","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.200755","article-title":"Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases","volume":"48","author":"Bachiller-Corral","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0041","first-page":"62","article-title":"Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry","volume":"0","author":"Sparks","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0042","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","author":"Jakub\u00edkov\u00e1","year":"2021","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152034_bib0043","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1136\/annrheumdis-2020-217509","article-title":"Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology practitioners from India","volume":"80","author":"Gupta","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152034_bib0044","unstructured":"DMARD Effects on COVID-19 Outcomes | RheumNow. Accessed August 2, 2021. https:\/\/rheumnow.com\/news\/dmard-effects-covid-19-outcomes."},{"key":"10.1016\/j.semarthrit.2022.152034_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0046","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152034_bib0047","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1007\/s11940-003-0025-9","article-title":"Dermatomyositis and Polymyositis","volume":"5","author":"Briemberg","year":"2003","journal-title":"Curr Treat Options Neurol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:41Z","timestamp":1758733721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":47,"alternative-id":["S0049017222000853"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152034","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152034"}}